Es gab 50 kürzliche Insider-Transaktionen für Cabaletta Bio, Inc. (CABA), darunter 37 Käufe und 12 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $32.42M und die gesamten Insider-Verkäufe auf $15.88M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Nichtberger Steven, Marda Anup, Chang David J.. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — CABA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-02 |
Nichtberger Steven |
President & CEO |
RSU-Zuteilung |
674,000 |
$3.30 |
$2.22M |
674,000 |
| 2026-03-02 |
Marda Anup |
Chief Financial Officer |
RSU-Zuteilung |
225,000 |
$3.30 |
$742.5K |
225,000 |
| 2026-03-02 |
Chang David J. |
Chief Medical Officer |
RSU-Zuteilung |
225,000 |
$3.30 |
$742.5K |
225,000 |
| 2026-03-02 |
Binder Gwendolyn |
President, Science & Tech. |
RSU-Zuteilung |
225,000 |
$3.30 |
$742.5K |
225,000 |
| 2026-03-02 |
Gerard Michael |
General Counsel |
RSU-Zuteilung |
175,000 |
$3.30 |
$577.5K |
175,000 |
| 2026-03-02 |
Das Arun |
Chief Business Officer |
RSU-Zuteilung |
175,000 |
$3.30 |
$577.5K |
175,000 |
| 2026-01-21 |
Simon Mark |
Director |
Informierter Kauf |
11,061 |
$2.28 |
$25.26K |
147,205 |
| 2026-01-21 |
Nichtberger Steven |
President & CEO |
Informierter Kauf |
45,000 |
$2.24 |
$100.78K |
1,031,483 |
| 2026-01-21 |
Tomasello Shawn |
Director |
Informierter Kauf |
22,725 |
$2.21 |
$50.32K |
22,725 |
| 2026-01-21 |
Bollard Catherine |
Director |
Informierter Kauf |
4,405 |
$2.27 |
$9.98K |
5,405 |
| 2026-01-21 |
Chang David J. |
Chief Medical Officer |
Informierter Kauf |
8,800 |
$2.26 |
$19.89K |
8,800 |
| 2026-01-21 |
Binder Gwendolyn |
President, Science & Tech. |
Informierter Kauf |
11,312 |
$2.19 |
$24.76K |
31,312 |
| 2026-01-21 |
Gerard Michael |
General Counsel |
Informierter Kauf |
6,600 |
$2.27 |
$14.98K |
6,600 |
| 2026-01-21 |
Gavel Steve |
Chief Commercial Officer |
Informierter Kauf |
22,170 |
$2.27 |
$50.22K |
22,170 |
| 2025-10-13 |
Gavel Steve |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-10-13 |
Gavel Steve |
Chief Commercial Officer |
RSU-Zuteilung |
275,000 |
$2.49 |
$684.75K |
275,000 |
| 2025-06-09 |
Henriques Richard C Jr |
Director |
RSU-Zuteilung |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Simon Mark |
Director |
RSU-Zuteilung |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Tomasello Shawn |
Director |
RSU-Zuteilung |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Bollard Catherine |
Director |
RSU-Zuteilung |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Brun Scott C. |
Director |
RSU-Zuteilung |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-05-19 |
Henriques Richard C Jr |
Director |
Aktienrückgabe |
22,000 |
$11.18 |
$245.96K |
- |
| 2025-05-19 |
Simon Mark |
Director |
Aktienrückgabe |
22,000 |
$10.01 |
$220.22K |
- |
| 2025-05-19 |
Nichtberger Steven |
President & CEO |
Aktienrückgabe |
411,600 |
$11.09 |
$4.56M |
- |
| 2025-05-19 |
Tomasello Shawn |
Director |
Aktienrückgabe |
44,000 |
$13.48 |
$593.12K |
- |
| 2025-05-19 |
Marda Anup |
Chief Financial Officer |
Aktienrückgabe |
130,000 |
$23.97 |
$3.12M |
- |
| 2025-05-19 |
Bollard Catherine |
Director |
Aktienrückgabe |
22,000 |
$10.01 |
$220.22K |
- |
| 2025-05-19 |
Chang David J. |
Chief Medical Officer |
Aktienrückgabe |
150,000 |
$11.09 |
$1.66M |
- |
| 2025-05-19 |
Binder Gwendolyn |
President, Science & Tech. |
Aktienrückgabe |
130,000 |
$23.97 |
$3.12M |
- |
| 2025-05-19 |
Brun Scott C. |
Director |
Aktienrückgabe |
22,000 |
$10.01 |
$220.22K |
- |
| 2025-05-19 |
Gerard Michael |
General Counsel |
Aktienrückgabe |
75,000 |
$3.21 |
$240.75K |
- |
| 2025-05-19 |
Das Arun |
Chief Business Officer |
Aktienrückgabe |
150,000 |
$11.09 |
$1.66M |
- |
| 2025-03-03 |
Nichtberger Steven |
President & CEO |
RSU-Zuteilung |
450,000 |
$1.67 |
$751.5K |
450,000 |
| 2025-03-03 |
Marda Anup |
Chief Financial Officer |
RSU-Zuteilung |
145,000 |
$1.67 |
$242.15K |
145,000 |
| 2025-03-03 |
Chang David J. |
Chief Medical Officer |
RSU-Zuteilung |
145,000 |
$1.67 |
$242.15K |
145,000 |
| 2025-03-03 |
Binder Gwendolyn |
President, Science & Tech. |
RSU-Zuteilung |
145,000 |
$1.67 |
$242.15K |
145,000 |
| 2025-03-03 |
Gerard Michael |
General Counsel |
RSU-Zuteilung |
115,000 |
$1.67 |
$192.05K |
115,000 |
| 2025-03-03 |
Das Arun |
Chief Business Officer |
RSU-Zuteilung |
115,000 |
$1.67 |
$192.05K |
115,000 |
| 2024-06-03 |
Henriques Richard C Jr |
Director |
RSU-Zuteilung |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Simon Mark |
Director |
RSU-Zuteilung |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Tomasello Shawn |
Director |
RSU-Zuteilung |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Bollard Catherine |
Director |
RSU-Zuteilung |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Brun Scott C. |
Director |
RSU-Zuteilung |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-03-01 |
Nichtberger Steven |
President & CEO |
RSU-Zuteilung |
353,000 |
$23.97 |
$8.46M |
353,000 |
| 2024-03-01 |
Marda Anup |
Chief Financial Officer |
RSU-Zuteilung |
130,000 |
$23.97 |
$3.12M |
130,000 |
| 2024-03-01 |
Chang David J. |
Chief Medical Officer |
RSU-Zuteilung |
130,000 |
$23.97 |
$3.12M |
130,000 |
| 2024-03-01 |
Binder Gwendolyn |
See Remarks |
RSU-Zuteilung |
130,000 |
$23.97 |
$3.12M |
130,000 |
| 2024-03-01 |
Gerard Michael |
General Counsel |
RSU-Zuteilung |
100,000 |
$23.97 |
$2.4M |
100,000 |
| 2024-03-01 |
Das Arun |
Chief Business Officer |
RSU-Zuteilung |
100,000 |
$23.97 |
$2.4M |
100,000 |
| 2024-01-19 |
Binder Gwendolyn |
See Remarks |
Informierter Verkauf |
700 |
$20.33 |
$14.23K |
20,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
